ばんどう内科・呼吸器クリニック

白山市布市の呼吸器内科、内科、アレルギー科｜
ばんどう内科・呼吸器クリニック

〒924-0808
石川県白山市布市1丁目113番地

076-277-6211

Menu

リサーチ

通院中の皆様や多くの医療機関にご協力いただいた
臨床研究をまとめた学術論文です

～ありがとうございます～

  1. Kawai N, Bando T, Goto T, Matsuura S, Nagao S, Tanaka O, Kawashima T, Chong Y, Ikematsu H.
    Durations of fever and other symptoms among COVID-19 outpatients administered Ensitrelvir during the 2023 Japanese XBB epidemic period.
    J Infect Chemother. 31: 102852, 2025. doi.10.1016/j.jiac.2025.102852.
  2. Goto T, Chong Y, Sato T, Tani N, Saiki S, Ishida S, Kawai N, Bando T, Ikematsu H.
    (Original article) Strain-specific anti-RBD IgG antibody titers against the WT, XBB.1.5, JN.1, and KP.3 strains consistently correlate with neutralizing activity following SARS-CoV-2 XBB.1.5-adapted mRNA vaccination.
    J Infect Chemother. 31: 102842, 2025. doi.10.1016/j.jiac.2025.102842.
  3. Kawai N, Ikematsu H, Bando T, Kawashima T, Matsuura S, Maeda T, Lee WJ, Nagao S, Yoshimura M, Mori K, Tanaka O, Doniwa K, Satoh I, Kashiwagi S.
    (Original article) Influenza vaccine effectiveness over 17 seasons in a large Japanese cohort: Analyses by age, virus type, underlying diseases and seasons before the COVID-19 pandemic.
    J Infect Public Health. 18: 102934, 2025. doi:10.1016/j.jiph.2025.102934.
  4. Bando T, Ikematsu H, Kawai N, Shibao K, Mizuguchi M, Amemiya T, Tsuchiya S, Oribe Y, Lee WJ, Maeda T, Kawashima T, Matsuura S, Doniwa K, Asamoto H, Sugawara M.
    (Original article) The effectiveness of repeated vaccination for COVID-19 symptom resolution during the KP.3-dominant epidemic period in Japan: A retrospective multicenter study.
    J Infect Chemother. 31: 102798, 2025. doi:10.1016/j.jiac.2025.102798.
  5. 嶋田由美子, 西谷章子, 澤野和彦, 坂東琢麿, 飯沼由嗣.
    （原著）白山ののいち地域における急性気道感染症に対する抗菌薬の使用に関する観察研究~傾向スコア分析による 2019 年と 2023 年調査の比較.
    日化療会誌. 73: 368-377, 2025.
  6. Kawai N, Ikematsu H, Bando T, Lee WJ, Matsuura S, Maeda T, Echizen M, Kawashima T.
    (Original article) Comparison of adverse reactions to COVID-19 XBB.1.5 and influenza vaccination in the 2023-24 Japanese influenza season. J Infect Chemother. 31: 102728, 2025. doi:10.1016/j.jiac.2025.10272.
  7. Goto T, Kawai N, Bando T, Sato T, Tani N, Chong Y, Ikematsu H.
    (Original article) In vitro neuraminidase inhibitory concentrations (IC50) of four neuraminidase inhibitors in the Japanese 2023-24 season: Comparison with the 2010-11 to 2022-23 seasons.
    J Infect Chemother. 31: 102602, 2025. doi:10.1016/j.jiac.2024.102602.
  8. 後藤健志, 坂東琢麿, 水口雅之, 織部芳隆, 谷直樹, 鄭湧, 池松秀之.
    （原著）オミクロン期（2022年1月から2023年3月）の成人軽症COVID-19患者を対象とした発熱および症状遷延に対するワクチン接種回数の影響についての検討.
    感染症誌. 98: 521-528, 2024. doi:10.11150/kansenshogakuzasshi.e24011.
  9. Goto T, Kawai N, Bando T, Takasaki Y, Shindo S, Sato T, Tani N, Chong Y, Ikematsu H.
    (Original article) Virological and clinical outcomes of influenza outpatients treated with baloxavir, oseltamivir, or laninamivir in the 2023–2024 season.
    Influenza Other Respir Viruses. 18: e70042, 2024. doi:10.1111/irv.70042.
  10. 坂東琢麿, 洞庭賢一, 池松秀之, 河合直樹
    （原著）日本国内第8波における新型コロナウイルス感染症の発症と遷延症状に関する観察研究～インフルエンザとの対比
    日臨内科医会誌. 38: 313-317, 2024.
  11. Goto T, Kawai N, Bando T, Tani N, Chong Y, Ikematsu H.
    (Original article) In vitro neuraminidase inhibitory concentrations (IC50) of four neuraminidase inhibitors in the Japanese 2022-23 season: Comparison with the 2010-11 to 2019-20 seasons.
    J Infect Chemother. 30:266-270, 2024. doi:10.1016/j.jiac.2023.10.009.
  12. Goto T, Kawai N, Bando T, Takasaki Y, Shindo S, Tani N, Chong Y, Ikematsu H.
    (Original article) Virological and clinical outcomes in outpatients treated with baloxavir or neuraminidase inhibitors for A(H3N2) influenza: A multicenter study of the 2022-2023 season.
    Antiviral Res. 224:105853, 2024. doi:10.1016/j.antiviral.2024.105853.
  13. 坂東琢麿, 水口雅之, 廣瀬達城, 織部芳隆.
    （原著）新型コロナウイルス感染症パンデミックにおける外来通院患者の日常生活での感染防護に関する観察研究～傾向スコア分析による2020年と2022年調査の比較検討
    日臨内科医会.誌38: 28-32, 2023.
  14. 坂東琢麿, 水口雅之, 廣瀬達城, 織部芳隆.
    （原著）新型コロナウイルス感染症パンデミックにおける外来患者の通院状況に関する観察研究～傾向スコア分析による2020年および2022年調査の比較検討
    日臨内科医会.誌38: 23-27, 2023.
  15. 坂東琢麿, 池松秀之, 河合直樹, 柏木征三郎.
    （原著）発症と発熱症状を指標とする新型コロナワクチンブースター接種の効果に関する日本国内第6波での観察研究
    日臨内科医会.誌37: 400-404, 2023.
  16. Tani N, Kawai N, Ikematsu H, Bando T, Iwaki N, Takasaki Y, Shindo S, Chong Y, Kashiwagi S.
    (Original article) Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate: A study of the 2017/18 and 2018/19 seasons and comparison with the 2011/12 to 2016/17 Japanese influenza seasons.
    J Infect Chemother. 28: 890-895, 2022. doi:10.1016/j.jiac.2022.03.008.
  17. Tani N, Kawai N, Chong Y, Bando T, Iwaki N, Kashiwagi S, Ikematsu H.
    (Original article) Susceptibility of epidemic viruses to neuraminidase inhibitors and treatment emergent resistance in the Japanese 2019-20 influenza season.
    J Infect. 84: 151-157, 2022. doi:10.1016/j.jinf.2021.11.020.
  18. Kato M, Saisho Y, Tanaka H, Bando T.
    (Original article) Improvement of respiratory symptoms and health-related quality of life with peramivir in influenza patients with chronic respiratory disease: Additional outcomes of a randomized, open-label study.
    Influenza Other Respir Viruses. 15: 651-660, 2021. doi:10.1111/irv.12835.
  19. Kato M, Saisho Y, Tanaka H, Bando T.
    (Original article) Effect of peramivir on respiratory symptom improvement in patients with influenza virus infection and pre-existing chronic respiratory disease: Findings of a randomized, open-label study.
    Influenza Other Respir Viruses. 15: 132-141, 2021. doi:10.1111/irv.12788.
  20. Chong Y, Kawai N, Tani N, Bando T, Takasaki Y, Shindo S, Ikematsu H.
    (Original article) Virological and clinical outcomes in outpatients treated with baloxavir or oseltamivir: A Japanese multicenter study in the 2019-2020 influenza season.
    Antiviral Res. 192: 105092, 2021. doi:10.1016/j.antiviral.2021.105092.
  21. Ikematsu H, Kawai N, Tani N, Chong Y, Bando T, Iwaki N, Kashiwagi S.
    (Original article) In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018-19 season: Comparison with the 2010-11 to 2017-18 seasons.
    J Infect Chemother. 26: 775-779, 2020. doi:10.1016/j.jiac.2020.03.001.
  22. Ikematsu H, Kawai N, Tani N, Chong Y, Iwaki N, Bando T, Tanaka O, Matsuura S, Maeda T, Doniwa K.
    (Note) Duration of fever and PA/I38X-substituted virus emergence in patients treated with baloxavir in the 2018-2019 influenza season.
    J Infect Chemother. 26: 400-402, 2020. doi:10.1016/j.jiac.2019.12.002.
  23. 池松秀之, 坂東琢麿, 洞庭賢一, 松浦伸郎, 鵜養宏, 前田哲也, 田中治, 岩城紀男, 川島崇, 若狭豊, 河合直樹, 柏木征三郎.
    （原著）13価結合型肺炎球菌ワクチン（PCV13）の65歳以上の高齢者へのインフルエンザワクチンとの同時期接種における安全性の検討.
    日臨内科医会誌. 34: 61-68, 2019.
  24. Ikematsu H, Kawai N, Chong Y, Bando T, Iwaki N, Kashiwagi S.
    (Original article) In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017-18 season: Comparison with the 2010-11 to 2016-17 seasons.
    J Infect Chemother. 25: 649-652, 2019. doi:10.1016/j.jiac.2019.04.007.
  25. 坂東琢麿, 土屋智, 浅本仁, 若井安理, 久保田公宣, 武内健一, 菅原正弘, 中佳一, 望月 紘一, 猿田享男.
    （原著）慢性閉塞性肺疾患（COPD）患者と医師に対するアンケート調査―実地診療における診断，治療，および増悪の現状―.
    日臨内科医会誌. 31: 566-572, 2016.
  26. 若井安理, 土屋智, 浅本仁, 坂東琢麿, 久保田公宣, 武内健一, 菅原正弘, 中佳一, 望月紘一, 猿田享男.
    （原著）プライマリケア医が認識していないCOPDの可能性と見逃している呼吸器症状；COPD Population Screener（COPD-PS）とCOPD Assessment Test（CAT）を用いたスクリーニング調査.
    日臨内科医会誌. 31: 559-565, 2016.